Lisa R.  Diller

Lisa R. Diller, MD

Chief Medical Officer, Dana-Farber/Boston Children's Cancer and Blood Disorders Center; Clinical Director, Pediatric Oncology; Medical Director, Clinical Cancer and Blood Disorders Service Line; Medical Director, David B. Perini, Jr. Quality of Life Clinic

Professor of Pediatrics, Harvard Medical School

  • Contact: 617-632-5642

  • Fax: 617-582-9049

Medical Services


  • Late Effects of Pediatric Cancer
  • Solid Tumors
  • Retinoblastoma
  • Wilms Tumor
  • Cancer Predisposition
  • Melanoma


  • Hematology / Oncology
  • Medicine


  • Center for Pediatric Polyposis
  • Neuroblastoma
  • David B. Perini Jr. Quality of Life Clinic
  • Pediatric Cancer Risk Program
To schedule an appointment: Call 617-632-5642

Experience and Education


Medical School

University of California, San Diego School of Medicine, 1985

San Diego, CA


Boston Children's Hospital, 1986

Boston, MA


Boston Children's Hospital, 1988

Boston, MA

Fellowship, Pediatric Hematology/Oncology

Boston Children's Hospital/Dana-Farber Cancer Institute, 1991

Boston, MA


  • Pediatrics, Pediatric Hematology/Oncology

Professional History

Dr. Lisa Diller is the Chief Medical Officer, Dana-Farber/Boston Children's Cancer and Blood Disorders Center. As a pediatric oncologist and the Clinical Director of Pediatric Oncology, she leads the joint clinical Pediatric Oncology Program at the Dana-Farber Cancer Institute and Boston Children's Hospital. She is also the Director of the Perini Family Survivors Center and the David B. Perini, Jr. Quality of Life Clinic for Cancer Survivors at Dana-Farber. She is a Professor of Pediatrics at Harvard Medical School. Dr. Diller received a bachelors degree from Harvard University, and earned her medical degree from the University of California at San Diego. She was a resident at Boston Children's Hospital and did her subspecialty training at Boston Children's Hospital/Dana-Farber Institute where she has been on the faculty for over 20 years. Dr. Diller's research focuses on the late effects of treatment for childhood cancer and genetic cancer predisposition syndromes in childhood. In addition, she investigates novel treatments for pediatric solid tumors, particularly tumors that occur in infants and toddlers.

To schedule an appointment: Call 617-632-5642


The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital 300 Longwood Avenue, Boston, MA 02115 617-355-6000 | 800-355-7944